Arsenal and other WSL clubs to trial alcohol in the stands

The Women’s Super League (WSL) will implement a pilot program to allow the consumption of alcohol in the stands of some matches, a measure that seeks to improve the experience of the fans. Prominent teams such as Arsenal, Chelsea, Liverpool, Manchester United, and Manchester City, along with other WSL and WSL2 clubs, will participate in this initiative.

Pilot Test Expansion

After a successful initial trial in the previous season, the WSL will expand this trial during the 2025-26 season. The trial, which began with some WSL2 clubs, will now include seven clubs from each division.

“Expanding this trial for the new campaign, encompassing our Barclays WSL teams and additional Barclays WSL2 clubs, is part of our strategy to offer the best experience to our fans attending the matches,” said Holly Murdoch, WSL Football’s Chief Operating Officer.

Holly Murdoch, WSL Football’s Chief Operating Officer

The initiative is not subject to the legislation governing alcohol consumption at sporting events in the UK, allowing the WSL to implement this trial.

Participating Clubs

The clubs that have confirmed their participation include Arsenal (Emirates Stadium), Chelsea (Kingsmeadow & Stamford Bridge), Everton (Goodison Park), Liverpool (St Helens & Anfield), London City Lionesses (Hayes Lane), Manchester City (Joie Stadium) and Manchester United (Leigh Sports Village & Old Trafford). In addition, Birmingham City (St Andrew’s), Bristol City (Ashton Gate), Crystal Palace (Sutton United), Newcastle United (St James’ Park), Sheffield United (Bramall Lane), Sunderland (Stadium of Light) and Southampton (St Mary’s Stadium) will join from the WSL2.

• Clubs will be able to decide in how many matches they will implement this measure.
• The designated areas within the stadiums will be communicated.

During the initial test, no security incidents were reported. 84% of the surveyed fans rated their feeling of security between 9 and 10 out of 10. Two-thirds of the respondents (66%) supported the continuation of the test, with 48% of them showing strong support.